Company
MedMen Enterprises Inc
CNSX:MMEN
MedMen Enterprises Inc is a cannabis retailer with flagship locations in California, Nevada, Illinois, Florida, and New York. The company offers a robust selection of high-quality products, including MedMen-owned brands LuxLyte and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. The company believes that a world where cannabis is legal and regulated is safer, healthier and happier.
50 stories · page 1 of 3
Buds & Duds: Cannabis stocks retreat; MedMen and Sundial lose CEOs
MedMen found its shares in the green but Sundial was not as fortunate
MedMen unveils plans to raise US74mln from offering of class B voting shares, sale of licenses in non-core states
The company said it expects to raise $54 million by selling licences in Arizona and in Illinois
Buds & Duds: Cannabis stocks higher on Thursday as troubled retailer MedMen reveals new round of layoffs
1933 Industries got a lift on a second licensing agreement in the US
Buds & Duds: Pot stocks retreat as MedMen, HEXO earnings disappoint
Cannabis analytics company CB2 Insights gained on new agreement with VIVO Cannabis
Buds & Duds: Cannabis stocks grow to end the week; HEXO falls on downgrade, job cuts
Among those making gains was MedMen, which announced the opening of two retail locations in Florida
Buds & Duds: Cannabis stocks slide on Monday but Flower One shares rise on positive earnings
Also on the move were ICC International Cannabis, MedMen, Isodiol International Tilray and TILT
Buds & Duds: Cannabis stocks plummet, but Canntab bucks the trend as shares rise
Also on the move were Cannabis One, Golden Leaf, Isodiol, MedMen, Tilray and Green Growth Brands
Buds & Duds: Cannabis stocks flatten out; Namaste shares climb in anticipation of financial results
Also on the move were Canntab Therapeutics, Cannabis One, WeedMD, Tilray, Isodiol and MedMen
Buds & Duds: Cannabis stocks flatten out; ICC International Cannabis shares jump earlier on Wednesday on European distribution deal
Also on the move were Namaste, True Leaf, Aleafia, Tilray and MedMen
Multistate US cannabis operators positioned to capture sizable market cap, Roth says
The US cannabis industry’s eight biggest multistate operators, according to Roth, are Green Thumb, MedMen, Curaleaf, iAnthus Capital, Acreage Holdings, Cresco Labs, Harvest Health and Columbia Care
Buds & Duds: Aurora gains as Cowen impressed with Nelson Peltz investment
Also representing the cannabis sector well Friday were 1933 Industries, MedMen and HarvestOne
MedMen posts 40% jump in fiscal 2Q sales, thanks to California sales
Eight stores in California accounted for the bulk of sales in its latest quarter
Buds & Duds: Dual-listed cannabis stocks surge in Canada, but sink in the US ahead of farm bill decision
The farm bill may legalize hemp and hemp-derived CBD in the US on the federal level
MedMen taps Michael Kramer as new CFO
Kramer joins MedMen after serving as chief financial officer of Apple Retail
MedMen completes acquisition to open first store in Arizona
The cannabis company gained control of Monarch, a dispensary, cultivator and processor of medical cannabis
Buds & Duds: Canopy Growth, Tilray, Aurora Cannabis, MedMen and other notable names take a hit
Cannabis-focused life-science company CV Sciences was one of the few gainers on the North American Marijuana Index
MedMen’s fiscal 1Q sales rocket 1,094% as losses widen due to expansion
Strong results in California drove MedMen’s fiscal first-quarter revenue to $21.5 million from the $1.8 million in the first quarter of fiscal 2018
Buds & Duds: Rough start to the week for cannabis stocks as Canopy Growth and Aurora Cannabis shares dip
GW Pharmaceuticals was a top gainer on the North American Marijuana Index following positive data from its trial of Epidiolex, a treatment for a form of childhood epilepsy
Buds & Duds: Cannabis stocks tank in general; CannaRoyalty Corp, Liberty Health Sciences Inc drop
The North American Marijuana Index had a tough day, down 4.62%